These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34869008)

  • 1. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview.
    Sun HC; Zhu XD
    Front Oncol; 2021; 11():772195. PubMed ID: 34869008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma.
    Takamoto T; Maruki Y; Kondo S
    Expert Opin Pharmacother; 2023; 24(14):1567-1575. PubMed ID: 37357809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate.
    Chen QF; Chen S; Chen M; Lyu N; Zhao M
    J Clin Transl Hepatol; 2024 Mar; 12(3):298-304. PubMed ID: 38426191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis.
    Chen X; Lai L; Ye J; Li L
    Front Oncol; 2021; 11():740762. PubMed ID: 34868936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheres.
    Wang EA; Stein JP; Bellavia RJ; Broadwell SR
    Int J Clin Pract; 2017 Nov; 71(11):. PubMed ID: 28758319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience.
    Tabone M; Calvo A; Russolillo N; Langella S; Carbonatto P; Lo Tesoriere R; Richetta E; Pellerito R; Ferrero A
    J Gastrointest Oncol; 2020 Feb; 11(1):84-90. PubMed ID: 32175109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of transarterial chemoembolization in downstaging unresectable hepatocellular carcinoma to curative therapy: a predicted regression model.
    Lin H; Luo B; Peng F; Fang C; Gan Y; Yang X; Li B; Li Y; Su S
    Invest New Drugs; 2022 Oct; 40(5):1146-1152. PubMed ID: 35723760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience.
    Zhang Y; Huang G; Wang Y; Liang L; Peng B; Fan W; Yang J; Huang Y; Yao W; Li J
    Oncologist; 2016 Dec; 21(12):1442-1449. PubMed ID: 27486202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition).
    Sun HC; Zhou J; Wang Z; Liu X; Xie Q; Jia W; Zhao M; Bi X; Li G; Bai X; Ji Y; Xu L; Zhu XD; Bai D; Chen Y; Chen Y; Dai C; Guo R; Guo W; Hao C; Huang T; Huang Z; Li D; Li G; Li T; Li X; Li G; Liang X; Liu J; Liu F; Lu S; Lu Z; Lv W; Mao Y; Shao G; Shi Y; Song T; Tan G; Tang Y; Tao K; Wan C; Wang G; Wang L; Wang S; Wen T; Xing B; Xiang B; Yan S; Yang D; Yin G; Yin T; Yin Z; Yu Z; Zhang B; Zhang J; Zhang S; Zhang T; Zhang Y; Zhang Y; Zhang A; Zhao H; Zhou L; Zhang W; Zhu Z; Qin S; Shen F; Cai X; Teng G; Cai J; Chen M; Li Q; Liu L; Wang W; Liang T; Dong J; Chen X; Wang X; Zheng S; Fan J;
    Hepatobiliary Surg Nutr; 2022 Apr; 11(2):227-252. PubMed ID: 35464283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
    Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.
    Wang MD; Xu XJ; Wang KC; Diao YK; Xu JH; Gu LH; Yao LQ; Li C; Lv GY; Yang T
    Cancer Sci; 2024 Jul; 115(7):2159-2169. PubMed ID: 38695305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
    Zhang ZF; Luo YJ; Lu Q; Dai SX; Sha WH
    World J Clin Cases; 2018 Sep; 6(9):259-273. PubMed ID: 30211206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage surgery following downstaging of unresectable hepatocellular carcinoma--a strategy to increase resectability.
    Lau WY; Lai EC
    Ann Surg Oncol; 2007 Dec; 14(12):3301-9. PubMed ID: 17891443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Current Status and Future Prospects for Conversion Therapy in the Treatment of Hepatocellular Carcinoma.
    Bai J; Huang M; Song B; Luo W; Ding R
    Technol Cancer Res Treat; 2023; 22():15330338231159718. PubMed ID: 36855803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial therapies in patients with hepatocellular carcinoma eligible for transarterial embolization: a US cost-effectiveness analysis.
    Patel MV; Davies H; Williams AO; Bromilow T; Baker H; Mealing S; Holmes H; Anderson N; Ahmed O
    J Med Econ; 2023; 26(1):1061-1071. PubMed ID: 37632520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
    Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
    Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
    Kutlu R; Karatoprak S
    J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.